Search

everythinglearnresearchcommunity

for

Search:↓

Maintaining sexual health after menopause is possible with patient approaches, hormone supplements, and therapy, despite needing more research.

PCOS increases sexual pain distress in infertile women.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Androgens affect many aspects of female health, and more research is needed to understand their roles and treatment potential.

Finasteride doesn't reduce sexual function in people with hair loss.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Medications for enlarged prostate can cause sexual side effects like reduced libido, erectile dysfunction, and ejaculatory problems.

Finasteride safely treats hair loss without harming hormones or reproduction, but may slightly reduce sexual function.

Testosterone is important for men's sexual function, may help some women's sexual desire, while other hormones and neurotransmitters also play complex roles in sexual behavior.

Testosterone pellets may help women's sexual function but have safety concerns and need more research.

Finasteride reduces hair loss and treats BPH without major hormone changes, but may cause sexual dysfunction.

Menopause often leads to lower sexual desire and discomfort during sex, but treatment should be personalized and only if it bothers the woman.

Woodhouse-Sakati syndrome often causes sexual development issues, hair loss, learning disabilities, deafness, muscle contractions, limb pain, and diabetes.

Trazodone and chlorpromazine may help treat sexual dysfunction caused by finasteride and SSRIs.

Many women experience sexual dysfunction, but few seek help, and better treatment and medical training are needed.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

Anabolic steroid abuse can cause sexual, fertility, and health problems.

Negative expectations can cause adverse effects in dermatology treatments, like with finasteride for baldness, and careful communication can help reduce these nocebo responses.

The treatment helped a transgender woman stop drinking, improved her mental health, and reduced her gender dysphoria.

Experts recommend thorough medical, sexual, and psychosocial assessments for women's sexual dysfunctions, and suggest individualized treatment plans with regular check-ups. They also mention potential use of estrogen and androgen therapy, but with caution due to safety concerns.

Laser pubic hair removal boosts self-esteem, body image, and sexual functions in women.

The document concludes that better research methods are needed in men's sexual health to provide stronger evidence and improve patient care.

Finasteride can reduce prostate cancer risk but may delay diagnosis and cause sexual side effects.

Hair loss in alopecia areata can negatively affect sexual quality of life.

Older men should openly discuss sexual health with doctors to improve their quality of life.